The emergence of Extended-Spectrum Beta-Lactamase (ESBL)-producing microorganisms in Brazilian hospitals is a challenge that concerns scientists, clinicians and healthcare institutions due to the serious risk they pose to confined patients. The goal of this study was the detection of ESBL production by clinical strains of Escherichia coli and Klebsiella sp. isolated from pus, urine and blood of patients at Hospital Universitário Santa Maria, Rio Grande Sul, RS, Brazil and the genotyping of the isolates based on bla SHV genes. The ESBL study was carried out using the Combined Disc Method, while Polymerase Chain Reaction (PCR) was used to study the bla SHV genes. Of the 90 tested isolates, 55 (61.1%) were identified as ESBL-producing by the combined disk method. The bla SHV genes were found in 67.8% of these microorganisms. K. pneumoniae predominated in the samples, presenting the highest frequency of positive results from the combined disk and PCR.
INTRODUCTION
Extended-spectrum beta-lactamases (ESBL) are enzymes that confer resistance to penicillins, cephalosporins of the first, second and third generations and aztreonam via hydrolysis of the antibiotics. ESBL are inactivated by beta-lactamase inhibitors such as clavulanic acid (10) .
Escherichia coli and Klebsiella pneumoniae are the most common ESBL producing bacterial species, although detection of these enzymes has been observed in various other species of Enterobacteriaceae and Pseudomonadaceae (6) . Patients with infections caused by ESBL-producing Enterobacteriaceae should not be treated with beta-lactam antibiotics due to the risks of therapeutic failure and increased infectiousness that could result in death (10) .
Production of ESBLs is an important mechanism of betalactam resistance in Enterobacteriaceae (13) . Early detection of multiresistant bacteria is important in defining therapies and for the isolation of patients, which is necessary to prevent the spread of these pathogens and also to prevent hospital-acquired (nosocomial) infections and outbreaks in the community (10, 15 (Table 2) . These results point to a probable detection failure in the test based on the inhibition of the enzyme by the clavulanic acid.
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Situations in which the inhibitory action of clavulanic acid can be masked include the coexistence of more than one enzyme that confers resistance, for example ESBL + AmpC type enzymes, changes in the pores of the cell membranes and TEM and SHV type beta-lactamases with a reduced affinity for betalactamases inhibitors (13, 16) . Also, the production of different types of beta-lactamases (TEM, SHV, CTX-M, OXA) by the same microorganism can lead to erroneous phenotypic conclusions (13) . In 2007, Tofteland et al. (17) reported that hyper-production of SHV-1 or SHV-11 can also be the cause of failure in ESBL detection when the combined disk method is used.
The combined disk method for phenotypic detection of ESBL production indicated a high prevalence of this type of resistance among samples taken at the HUSM (61.1%).
However, the detection of this type of resistence was even higher when PCR was used. In a scenario of increasing microbial resistance to antibiotics, this result corroborates the known limitations of the phenotypic methods, reinforcing the need for molecular methods such as PCR for identification of ESBL producing microorganisms.
